Ember Therapeutics Inc., a Boston start-up looking to build a portfolio of intellectual property related to brown fat, said yesterday that it has completed a licensing agreement with the Joslin Diabetes Center.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?